Human Pharmaceutical Portfolio

Aprecap Capsule

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthAprepitant 125 mg + Aprepitant 80 mg
ManufacturerGlenmark Pharmaceuticals Ltd
CategoryNausea
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.